Novo Nordisk A/SNOVO-B.CO
Last updated: May 30, 2026 at 02:35 AM
Trend
Novo Nordisk A/S shows a cautious picture. The EMA crossover shows no clear direction.
Momentum
RSI at 61.2 shows positive momentum.
Sector Performance
52-week return of -30.1% is below the Healthcare sector average of +25.9%.
Sector Ranking
#14 of 17 Healthcare titles in the Edgio universe by composite score.
Performance
1 day
-0.2%
4 weeks
+10.5%
52 weeks
-30.1%
Signal Analysis in Detail
EMA Crossover — Trend Direction
MIXEDCompares a fast moving average to a slow one. When the fast is above the slow, the trend is positive. Period settings are automatically calibrated per asset class.
Novo Nordisk A/S shows no clear trend — the moving averages are close together. In such phases, trend signals are less reliable as the market moves sideways.
RSI — Momentum Strength
61.2The Relative Strength Index measures the ratio of upward to downward price movements over the last 14 trading days on a scale of 0 to 100. Readings above 55 confirm positive momentum, below 45 negative.
RSI stands at 61.2 — in the neutral zone between 45 and 55. Neither buyers nor sellers are clearly dominant. Momentum is balanced, which in combination with a clear EMA trend suggests a stable phase, but with a neutral trend indicates directionlessness.
Williams %R — Position in Trading Range
-47.8Williams %R shows where the current price sits within the high-low range of the last 14 trading days. Values near 0: price at the top. Values near -100: at the bottom.
Williams %R stands at -47.8 — a neutral position. The price is in the middle of the recent trading range, without extremes in either direction.
More Healthcare titles
Eli Lilly and Company
Merck & Co., Inc.
Merck KGaA
AbbVie Inc.
Roche Holding AG
UnitedHealth Group Incorporated
Full Analysis with 16 Signals
This page shows 3 of 16 signals. The full analysis includes:
Trend
- MA Trend Filter
- ADX Direction
- ADX Trend Strength
- Regression Intercept
Momentum
- MACD
- Rate of Change
- 52-Week High
- Momentum Oscillator
Oscillators
- Stochastic
Macro & Relative
- VIX Level
- VIX Rate of Change
- HY Spread
- Relative Strength
Plus: analysis in the context of your entire portfolio — correlations, risk budget, rebalancing recommendations.
Join the waitlistYour portfolio, 16 signals, one score.
Import your portfolio and see where you stand — with daily signal updates, risk metrics, and actionable recommendations.
Join the waitlistThe information presented does not constitute investment advice and should not be construed as a solicitation to buy or sell financial instruments. Past performance is not a reliable indicator of future results. Any investment decision should be based on your own research and, where appropriate, professional advice.